These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2452305)
1. Prolonged inhibitory effects of nilvadipine (FR34235) following washout in isolated rabbit aorta and mesenteric artery. Furuta T J Cardiovasc Pharmacol; 1988 Feb; 11(2):134-8. PubMed ID: 2452305 [TBL] [Abstract][Full Text] [Related]
2. Effects of nilvadipine on the cardiovascular system in experimental animals. Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444 [TBL] [Abstract][Full Text] [Related]
3. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta. Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y Arch Int Pharmacodyn Ther; 1991; 312():86-103. PubMed ID: 1663336 [TBL] [Abstract][Full Text] [Related]
4. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium. Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975 [TBL] [Abstract][Full Text] [Related]
5. Possible mechanisms underlying the midazolam-induced relaxation of the noradrenaline-contraction in rabbit mesenteric resistance artery. Shiraishi Y; Ohashi M; Kanmura Y; Yamaguchi S; Yoshimura N; Itoh T Br J Pharmacol; 1997 Jul; 121(6):1155-63. PubMed ID: 9249252 [TBL] [Abstract][Full Text] [Related]
6. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [TBL] [Abstract][Full Text] [Related]
7. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries. Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741 [TBL] [Abstract][Full Text] [Related]
8. New dihydropyridine drug, nilvadipine, blocks the calcium slow action potential in rat-cultured aortic smooth muscle cells. Bkaily G; Molyvdas PA; Ousterhout J; Sperelakis N Eur J Pharmacol; 1986 May; 124(1-2):59-65. PubMed ID: 3720845 [TBL] [Abstract][Full Text] [Related]
9. Effects of calcium channel entry blockers, nifedipine and nilvadipine, on colonic motor activity. Barone FC; White RF; Ormsbee HS; Wasserman MA J Pharmacol Exp Ther; 1986 Apr; 237(1):99-106. PubMed ID: 2420971 [TBL] [Abstract][Full Text] [Related]
10. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries. Hondeghem LM; Ayad MJ; Robertson RM J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium. Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1722-30. PubMed ID: 3219148 [TBL] [Abstract][Full Text] [Related]
12. Effects of nifedipine on smooth muscle cells of the rabbit mesenteric artery. Kanmura Y; Itoh T; Suzuki H; Ito Y; Kuriyama H J Pharmacol Exp Ther; 1983 Jul; 226(1):238-48. PubMed ID: 6864542 [TBL] [Abstract][Full Text] [Related]
13. Effects of Ca antagonists on Ca fluxes in resistance vessels. Cauvin C; Saida K; van Breemen C J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S287-90. PubMed ID: 6184554 [TBL] [Abstract][Full Text] [Related]
14. Effects of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats. Takakura S; Satoh Y; Satoh H; Mori J; Kohsaka M Arch Int Pharmacodyn Ther; 1992; 319():38-48. PubMed ID: 1285672 [TBL] [Abstract][Full Text] [Related]
15. Antagonism of Ca2+-induced constriction of isolated rabbit ear artery by nitrendipine in high K+- and/or norepinephrine-containing medium. Scriabine A; Johnson CE; Steinsland OS; Anderson CL J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S944-8. PubMed ID: 6085382 [TBL] [Abstract][Full Text] [Related]
16. The mode of vasorelaxant action of 2-aminoisoquinoline, 1.3 (2H.4H)-dione, a novel 'intracellular calcium inhibitor'. Hester RK; Satake N; Shibata S; Ueda S; Yamahara J Br J Pharmacol; 1986 Feb; 87(2):387-93. PubMed ID: 3082401 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure. Dong H; Earle ML; Jiang Y; Loutzenhiser KA; Triggle CR Br J Pharmacol; 1997 Dec; 122(7):1271-8. PubMed ID: 9421272 [TBL] [Abstract][Full Text] [Related]
18. Vasodilation profile of CD-832, a novel dihydropyridine derivative in rabbit aorta. Noguchi K; Takahashi K; Araki H; Higuchi S Gen Pharmacol; 1997 Sep; 29(3):361-6. PubMed ID: 9378240 [TBL] [Abstract][Full Text] [Related]
19. Mode of vasorelaxing action of 5-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]-1-oxopropyl]-2,3,4,5- tetrahydro-1,5-benzothiazepine fumarate (KT-362), a new intracellular calcium antagonist. Shibata S; Wakabayashi S; Satake N; Hester RK; Ueda S; Tomiyama A J Pharmacol Exp Ther; 1987 Jan; 240(1):16-22. PubMed ID: 3100766 [TBL] [Abstract][Full Text] [Related]
20. Vasodilator mechanism of KB-944, a new calcium antagonist. Morita T; Kanazawa T; Ito K; Nose T Arzneimittelforschung; 1982; 32(9):1043-6. PubMed ID: 6890823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]